Sign In
Get Clay Free →

Suggestions

    Barbara Natke

    Acting Vice President, Business Development, Strategy and Program Managment

    Professional Background

    Barbara Natke has established herself as a leader in the biopharmaceutical industry, combining her deep expertise in biochemistry with a strategic business acumen. Currently serving as the Senior Director and Acting Vice President of Business Development, Strategy, and Program Management at Samyang Biopharm USA, Barbara plays a pivotal role in guiding the organization through the complexities of biopharmaceutical development. Her leadership is instrumental in driving growth and optimizing program management across multiple initiatives that are crucial to the company's success.

    Before her current position, Barbara accumulated a wealth of experience across several prestigious organizations. Her journey commenced with her role as a Senior Scientist at Sanofi Genzyme, where she contributed to innovative research and product development. Pursuing a passion for scientific exploration, she later transitioned to the role of Application Scientist at Ciphergen Biosystems before advancing to Senior Research Scientist at CereMedix. Her ascent continued as she took on a significant role at Consensus Pharmaceuticals as a Senior Scientist, and eventually moved on to become a Principal Scientist and Associate Director at Shire.

    At Shire, she sharpened her focus on R&D due diligence as the Director, where she aligned clinical development initiatives with strategic business goals, showcasing her ability to integrate scientific insight with corporate strategy. This unique perspective is a result of her diverse background, allowing her to understand the multifaceted nature of biopharmaceutical challenges and opportunities.

    Barbara's postdoctoral fellowship at the Massachusetts Institute of Technology (MIT) further solidified her foundation in research and development, propelling her career forward in the competitive landscape of biopharmaceuticals.

    Education and Achievements

    Barbara Natke's educational background is as impressive as her professional journey. She earned her Bachelor of Science in Biology from Loyola University of Chicago, laying the groundwork for her passion in the biological sciences. Recognizing her potential for advanced studies, she pursued a PhD in Biochemistry at Boston University School of Medicine, where she honed her research skills and deepened her understanding of complex biological processes.

    Further demonstrating her commitment to professional development, Barbara obtained a Master of Business Administration (MBA) from the F.W. Olin Graduate School of Business, graduating Magna Cum Laude. This combination of scientific knowledge and business acumen equips her to navigate the intricate world of biopharmaceuticals, where both innovation and market strategy are critical for success.

    Achievements

    Throughout her career, Barbara Natke has achieved notable contributions to the field of biopharmaceutical development. Her expertise in business development and program management is evidenced by her successful leadership in various projects at Samyang Biopharm USA. As a thought leader, she has been influential in guiding teams through rigorous development processes, ensuring that scientific innovation aligns with business objectives.

    Barbara’s tenure at Shire and other organizations has been marked by significant contributions to advancing therapeutic solutions and solidifying strategic partnerships that enhance clinical development. Her strategic foresight and scientific understanding have enabled her to make decisions that are not only informed by the latest research but also in tune with market needs.

    As a result of her extensive experience, Barbara is often sought after as a mentor and consultant, sharing her insights into effective program management and innovative R&D practices. She embodies a blend of deep scientific knowledge and strategic thinking, making her a valuable asset to the teams she collaborates with.

    In conclusion, Barbara Natke's professional journey reflects a commitment to excellence in both science and business. Her educational background in biology, biochemistry, and business has equipped her with a unique perspective that she brings to her leadership roles. With a track record of impactful contributions in various high-profile organizations, Barbara is well-positioned to continue making significant strides in the biopharmaceutical industry.

    Related Questions

    How did Barbara Natke transition from biochemistry to business development in the biopharmaceutical sector?
    What specific projects has Barbara Natke led at Samyang Biopharm USA that highlight her leadership skills?
    In what ways has Barbara Natke contributed to the success of R&D initiatives during her tenure at Shire?
    What were some key learnings Barbara Natke gained during her postdoctoral fellowship at MIT that have influenced her career?
    How does Barbara Natke leverage her MBA to enhance her effectiveness in biopharmaceutical strategy and program management?
    Barbara Natke
    Add to my network

    Location

    Greater Boston